MIRA INFORM
REPORT
|
Report Date : |
04.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
PELLA PHARMACEUTICAL CO |
|
|
|
|
Registered Office : |
Al Hassan Industrial
Zone, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
11.11.2007 |
|
|
|
|
Com. Reg. No.: |
15244, Irbid |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceutical preparations, hair products, hair removal products, sun protection cream and insect bites cream |
|
|
|
|
No. of Employees
: |
35 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Jordan |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : PELLA PHARMACEUTICAL CO LTD
Country of Origin : Jordan
Legal Form : Limited Liability Company
Registration Date : 11th November 2007
Commercial Registration Number : 15244, Irbid
National ID Number : 200091116
Issued Capital : JD 1,000,000
Paid up Capital : JD 1,000,000
Total Workforce : 35
Activities :
Manufacturers of pharmaceutical preparations, hair products, hair
removal products, sun protection cream and insect bites cream.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 150,000
Person Interviewed : Baha Al Khateeb, Production Manager
PELLA
PHARMACEUTICAL CO LTD
Registered &
Physical Address
Location : Al Hassan Industrial Zone
PO Box : 77, Irbid
226, Amman
Town : Irbid 21467
Country : Jordan
Telephone : (962-2) 7395361
Facsimile : (962-2) 7395395
Mobile : (962-79) 9923250
Email : info@dermapharma.jo
Premises
Subject operates
from a medium sized suite of offices and a factory that are rented and located
in the Industrial Area of Irbid.
Branch Offices
Location Description
·
Khalda
Area Office
premises
Amman
Tel: (962-6) 5339990
Fax: (962-6) 5357045
Name Position
·
Dr Mohamed Ali Al Rashadan Managing
Director
·
Dr Bashar Tawfiq Batayinah Director
·
Dr Medhat Mohamed Abdo Al Malik Director
·
Omar Ahmed Batayinah Director
·
Mahmoud Samreen Finance
Manager
·
Baha Al
Khateeb Production
Manager
Date of Establishment : 11th
November 2007 (Production began in the 2nd quarter of 2010)
Legal Form :
Limited Liability Company
Commercial Reg. No. : 15244, Irbid
National ID No. :
200091116
Issued Capital : JD 1,000,000
Paid up Capital : JD 1,000,000
Name of
Shareholder (s)
·
Dr Mohamed Ali Al Rashadan
·
Dr Bashar Tawfiq Batayinah
·
Dr Medhat Mohamed Abdo Al Malik
·
Omar Ahmed Batayinah
Activities: Engaged in the manufacture of
pharmaceutical preparations, hair
products, hair removal products, sun
protection cream and insect
bites cream.
Import
Countries: Europe and the
Far East.
Brand Names: MUSTAL SOLUTION, FLOREXA CREAM, FOTOBLOCK
PLUS and FOTOBLOCK CREAM
Subject has a
workforce of 35 employees.
Companies registered
in Jordan are not legally required to make their accounts public and no
financial information was released by the company or submitted by outside
sources.
·
Arab
Bank Plc
King Abdullah Square
PO Box: 16
Irbid
Tel: (962-2) 7242251
Fax: (962-2) 7277596
No complaints
regarding subject’s payments have been reported.
Local sources
report that payment obligations are met in a generally timely manner and the operating
history is clear. As such the company is deemed a fair trade risk and the above
credit figure is considered to be within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.56 |
|
UK Pound |
1 |
Rs.81.05 |
|
Euro |
1 |
Rs.67.49 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.